Adult Acute Myeloblastic Leukemia Without Maturation (M1) Completed Phase 3 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0028523 (Adult Acute Myeloblastic Leukemia Without Maturation (M1))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006363Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaTreatment
NCT00003190Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid LeukemiaTreatment